Anatomical Therapeutic Chemical • L01EC01 • vemurafenib

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01A Alkylating agents

L01B Antimetabolites

L01C Plant alkaloids and other natural products

L01D Cytotoxic antibiotics and related substances

L01E Protein kinase inhibitors

L01EA BCR-ABL tyrosine kinase inhibitors

L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

L01EC B-raf serine-threonine kinase (BRAF) inhibitors

L01EC01 vemurafenib

L01EC02 dabrafenib

L01EC03 encorafenib

L01ED Anaplastic lymphoma kinase (ALK) inhibitors

L01EE Mitogen-activated protein kinase (MEK) inhibitors

L01EF Cyclin-dependent kinase (CDK) inhibitors

L01EG Mammalian target of rapamycin (MTOR) kinase inhibitors

L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors

L01EJ Janus-associated kinase (JAK) inhibitors

L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors

L01EL Bruton's tyrosine kinase (BTK) inhibitors

L01EM Phosphatidylinositol-3-kinase (PI3K) inhibitors

L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors

L01EX Other protein kinase inhibitors

L01F Monoclonal antibodies and antibody drug conjugates

L01X Other antineoplastic agents

L02 Endocrine therapy

L03 Immunostimulants

L04 Immunosuppressants

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various

OTHER INFORMATION ABOUT ATC CODES (Anatomical Therapeutic Chemical)

J05AF05

Lamivudine

Antiinfectives for systemic use
Direct acting antivirals
Nucleoside and nucleotide reverse transcriptase inhibitors

D07AD01

Clobetasol

Dermatologicals
Corticosteroids, plain
Corticosteroids, very potent (group iv)

G04CXN3

Plants

Genito urinary system and sex hormones
Drugs used in benign prostatic hypertrophy
Other drugs used in benign prostatic hypertrophy

L01XK04

Talazoparib

Antineoplastic and immunomodulating agents
Other antineoplastic agents
Poly (ADP-ribose) polymerase (PARP) inhibitors

C07AB14

Landiolol

Cardiovascular system
Beta blocking agents
Beta blocking agents, selective

A01AA01

Sodium fluoride

Alimentary tract and metabolism
Stomatological preparations
Caries prophylactic agents

V06DDN1

Amino acids

Various
Other nutrients
Amino acids, incl. combinations with polypeptides

D11AH02

Pimecrolimus

Dermatologicals
Other dermatological preparations
Agents for dermatitis, excluding corticosteroids

G04CX

Homeopathic

Genito urinary system and sex hormones
Drugs used in benign prostatic hypertrophy
Other drugs used in benign prostatic hypertrophy

J07XN09

Miscellaneous

Antiinfectives for systemic use
Other vaccines

L04AA29

Tofacitinib

Antineoplastic and immunomodulating agents
Immunosuppressants
Selective immunosuppressants

L01DC01

Bleomycin sulfate

Antineoplastic and immunomodulating agents
Cytotoxic antibiotics and related substances
Other cytotoxic antibiotics